L
Lantern
Health Tech & Medtech · Dallas, United States · Founded 2010
Formerly known as Employer Direct Healthcare | Specialty care platform for employer health plans. MoreLess
Lantern operates as a specialty care platform designed to connect members of self-funded employer health plans with high-quality, cost-effective medical care for complex needs. The company, headquartered in Dallas, Texas, targets the highest-cost areas of healthcare spend for employers, which include surgery, cancer care, and infusion therapies. Lantern's business model is centered on providing a supplemental health benefit to large employers, public sector entities, and labor unions. It curates a proprietary "Network of Excellence" by directly contracting with top-performing specialists and facilities, including ambulatory surgery centers and hospitals, across the United States. This model aims to deliver significant cost savings to employers—reportedly over 55% lower rates than average health plans—while improving clinical outcomes for patients. The company was founded in 2010, and was previously known as Employer Direct Healthcare and operated with SurgeryPlus as its core product. In September 2024, the company rebranded to Lantern to reflect its expansion beyond surgery into a multi-faceted specialty care platform. John Zutter, who has a background in investment banking and private equity with J.P. Morgan and Dundon Capital Partners, joined as CEO in 2016. Under his leadership, Lantern grew from approximately 100,000 members to over 6 million, serving more than 1,000 employers. The company's growth was supported by several funding rounds, including a $30 million investment in March 2026 led by Morgan Health, a JPMorgan Chase business unit, and Echo Health Ventures. Lantern's platform functions as an evolution of the traditional Centers of Excellence (COE) model by emphasizing local, accessible care to drive higher utilization. The company reports that providing local access can increase utilization by five to eight times compared to models requiring travel. For members, Lantern provides a dedicated care team of care advocates and nurses who offer personalized support throughout their entire treatment journey, from diagnosis and scheduling to post-treatment follow-up. This service helps members navigate the complex healthcare system, access second opinions, and get scheduled for care faster than the national average. The platform's key services cover planned surgeries, comprehensive cancer care, and both in-home and ambulatory infusion therapies. Keywords: specialty care platform, employer health benefits, centers of excellence, bundled payments, surgery benefits management, cancer care solutions, infusion therapy services, healthcare cost containment, self-funded employers, care navigation, high-performance provider network, value-based healthcare, employee health plans, healthcare savings, direct contracting, John Zutter, Morgan Health, Employer Direct Healthcare, SurgeryPlus, corporate health, managed care, healthcare TPA, medical cost management, oncology care, provider network
Company overview
Lantern company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2010
- Headquarters
- Dallas, United States
- Employees
- 720
- Open positions
- None listed
- Dealroom signal
- 91.0
Valuation & funding
Lantern funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GROWTH EQUITY VC✓Equity / VC | Mar 2026 | $30M | — | Echo Health Ventures · Morgan Health | ↗ |
| SECONDARY✓Other financing | Dec 2023 | $92M | $1B | Insight Partners | ↗ |
| ACQUISITION✓Exit | Sep 2023 | $0 | — | Risk Strategies | ↗ |
| GROWTH EQUITY VC✓Equity / VC | Oct 2020 | — | — | Serent Capital | — |
| SERIES C✓Equity / VC | Jan 2016 | $0 | — | Dundon capital partners | — |
| SERIES B✓Equity / VC | Feb 2015 | TEXO Ventures | — | ||
| SERIES B✓Equity / VC | Feb 2014 | TEXO Ventures | — | ||
| SERIES B✓Equity / VC | Nov 2012 | TEXO Ventures | — | ||
| SERIES A✓Equity / VC | May 2010 | TEXO Ventures | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 720 |
| 2025 | 607 |
| 2024 | 440 |
| 2023 | 222 |
| 2022 | 187 |
| 2021 | 143 |
| 2020 | 88 |
Growth signals
Lantern website traffic
Latest recorded traffic for Lantern is 31K monthly website visits, up 5640.7% over the last three months. Lantern's team grew 18.6% over the past year.
Comparisons
Lantern compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Lantern's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Lantern has talent and traffic
team presence
In the news
Latest news about Lantern
Recent press, funding announcements, and product moves mentioning Lantern — open to read from the original sources.
Market sentiment
What the market is saying about Lantern
An AI-synthesized read of the highest-engagement posts about Lantern on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lantern’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.

















